American scientists have invented a type of oral medication that appears to be effective in treating smallpox. The smallpox virus is deadly and could potentially be used by terrorists for microbial attacks. The new drug is derived from an injectable smallpox medication called 'cidofovir.' Scientists from the University of California in San Diego and the U.S. Army's Microbial Anti-Terrorism Laboratory in Maryland have developed this new oral anti-smallpox drug, which has a long abbreviation 'C.D.P.C.D.V.' The drug has been tested on mice and has shown a 100% positive result. Smallpox kills 30% of those infected. The disease was eradicated over twenty years ago, but due to the threat of terrorists attempting to spread the virus among urban populations to cause mass casualties, the U.S. government has quickly sought to find a vaccine for this disease and also to develop a more effective vaccine to combat anthrax.
Invention of Anti-Smallpox Drug - 2002-03-21
American scientists have developed a new oral medication for smallpox, derived from an existing injectable drug. This development is crucial as the smallpox virus poses a potential threat for bioterrorism. The U.S. government is actively seeking solutions to counteract this threat.
👥 Key Players
📰 What Happened
American scientists have developed a new oral medication for smallpox, derived from an existing injectable drug. This new drug shows promise in treating smallpox, which is a potential bioterrorism threat.
- The smallpox virus has a 30% mortality rate among those infected.
- The drug has shown a 100% effectiveness rate in tests conducted on mice.
💡 Why It Matters
📚 Background
Smallpox was eradicated in 1980, but its potential use as a bioweapon remains a concern for governments worldwide. The development of effective treatments is crucial for public health safety.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%